)
)
)
Polaris Quantum Biotech
Polaris Quantum Biotech (PolarisQB) pioneered the first drug discovery platform built directly on quantum computing infrastructure. The company combines quantum computing, artificial intelligence, and machine learning to accelerate early-stage pharmaceutical research, fundamentally transforming how novel drug candidates are identified from vast chemical spaces.
Quantum-Aided Drug Design (QuADD) is PolarisQB's flagship SaaS platform that leverages quantum annealing technology to solve the multi-objective optimization problems central to computational drug discovery. QuADD explores chemical spaces comprising up to 10^30 theoretical molecular candidates - a space approximately 20 orders of magnitude larger than conventional computational methods - identifying optimized, synthesizable lead compounds in 1–3 days rather than years. QuADD natively optimizes for critical pharmaceutical properties, including binding affinity, drug-like properties, and synthetic accessibility.
Address
NCUnited States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)